Skip to content

Sofinnova Investments, Inc.

Follow

13F filer, CIK 1631134, Menlo Park, CA

Sofinnova Investments, Inc. reported $2,301,502,546 across 67 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 67.41% of the portfolio.

Accepted , ingested 13F-HR 0001104659-26-128032

Period
2026-09-30
Reported value
$2.3B
Holdings
67
Top 10 weight
67.41%
New
23
Sold out
13

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AZNnew+383,053$61.9M
AXSMadded+285,477$52.6M
LLYnew+43,777$50.7M
NVSnew+196,700$28M
ALNYnew+112,879$27.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SUPNexited-1,036,328-$48.2M
GILDexited-343,100-$43.3M
COGTexited-1,035,148-$40.1M
BMYreduced-547,003-$34.1M
UTHRreduced-39,998-$21.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-128032, largest first. % of portfolio is the value over $2,026,692,127, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,550,280 shares; 2025Q1: 1,550,280 shares; 2025Q2: 1,550,280 shares; 2025Q3: 1,550,280 shares; 2025Q4: 1,550,280 shares; 2026Q1: 1,550,280 shares; 2026Q2: 1,550,280 shares; 2026Q3: 1,550,280 shares 1,550,280$641M31.62%0Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 752,261 shares; 2026Q2: 4,045,215 shares; 2026Q3: 4,349,551 shares 4,349,551$155M7.66%+304,336Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 504,193 shares; 2025Q1: 510,050 shares; 2025Q2: 694,096 shares; 2025Q3: 588,828 shares; 2025Q4: 959,860 shares; 2026Q1: 598,327 shares; 2026Q2: 365,341 shares; 2026Q3: 422,375 shares 422,375$97.8M4.83%+57,034Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,793,987 shares; 2025Q1: 2,793,987 shares; 2025Q2: 2,793,987 shares; 2025Q3: 2,793,987 shares; 2025Q4: 2,793,987 shares; 2026Q1: 2,793,987 shares; 2026Q2: 2,793,987 shares; 2026Q3: 2,793,987 shares 2,793,987$90.2M4.45%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 491,726 shares; 2025Q1: 175,317 shares; 2025Q2: 93,610 shares; 2025Q3: 393,499 shares; 2025Q4: 12,266 shares; 2026Q1: 212,747 shares; 2026Q2: 160,429 shares; 2026Q3: 445,906 shares 445,906$82.2M4.06%+285,477Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,564,871 shares; 2026Q3: 3,564,871 shares 3,564,871$71.9M3.55%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,995,594 shares; 2025Q1: 1,995,594 shares; 2025Q2: 1,995,594 shares; 2025Q3: 1,947,579 shares; 2025Q4: 1,904,408 shares; 2026Q1: 1,904,408 shares; 2026Q2: 1,904,408 shares; 2026Q3: 1,904,408 shares 1,904,408$64M3.16%0Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 456,031 shares; 2026Q2: not reported; 2026Q3: 383,053 shares 383,053$61.9M3.05%newTimeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,696,752 shares; 2025Q1: 1,696,752 shares; 2025Q2: 1,696,752 shares; 2025Q3: 1,696,752 shares; 2025Q4: 1,696,752 shares; 2026Q1: 1,696,752 shares; 2026Q2: 1,696,752 shares; 2026Q3: 1,696,752 shares 1,696,752$51.4M2.54%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 397,428 shares; 2025Q1: 446,839 shares; 2025Q2: 586,010 shares; 2025Q3: 246,966 shares; 2025Q4: 271,394 shares; 2026Q1: 450,096 shares; 2026Q2: 408,027 shares; 2026Q3: 534,538 shares 534,538$50.9M2.51%+126,511Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,364 shares; 2025Q1: 52,800 shares; 2025Q2: 97,018 shares; 2025Q3: not reported; 2025Q4: 61,652 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 43,777 shares 43,777$50.7M2.5%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,071,498 shares; 2025Q1: 716,896 shares; 2025Q2: 614,865 shares; 2025Q3: 985,828 shares; 2025Q4: 2,254,161 shares; 2026Q1: 1,633,897 shares; 2026Q2: 1,658,384 shares; 2026Q3: 2,511,006 shares 2,511,006$40.5M2%+852,622Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 527,190 shares; 2025Q1: 697,916 shares; 2025Q2: 708,678 shares; 2025Q3: 440,092 shares; 2025Q4: 454,657 shares; 2026Q1: 406,029 shares; 2026Q2: 303,103 shares; 2026Q3: 391,621 shares 391,621$39.2M1.93%+88,518Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,069,090 shares; 2025Q1: 2,622,192 shares; 2025Q2: 2,147,795 shares; 2025Q3: 922,695 shares; 2025Q4: 885,121 shares; 2026Q1: 1,131,786 shares; 2026Q2: 925,119 shares; 2026Q3: 946,340 shares 946,340$36.4M1.79%+21,221Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 746,824 shares; 2025Q1: 788,666 shares; 2025Q2: 778,476 shares; 2025Q3: 436,051 shares; 2025Q4: 1,618,477 shares; 2026Q1: 1,701,904 shares; 2026Q2: 1,720,316 shares; 2026Q3: 1,627,469 shares 1,627,469$35M1.73%-92,847Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 343,206 shares; 2025Q1: 1,554,304 shares; 2025Q2: 2,240,528 shares; 2025Q3: 2,227,837 shares; 2025Q4: 3,435,542 shares; 2026Q1: 3,630,454 shares; 2026Q2: 3,669,346 shares; 2026Q3: 3,585,506 shares 3,585,506$31.5M1.55%-83,840Timeline
NVSNOVARTIS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 196,700 shares 196,700$28M1.38%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 110,157 shares; 2025Q1: 176,181 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 112,879 shares 112,879$27.9M1.37%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 83,300 shares; 2026Q1: 3,145,888 shares; 2026Q2: 1,717,505 shares; 2026Q3: 1,753,703 shares 1,753,703$26.4M1.3%+36,198Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 697,133 shares; 2026Q1: 781,982 shares; 2026Q2: 358,568 shares; 2026Q3: 432,695 shares 432,695$26M1.28%+74,127Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 371,497 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,512,994 shares; 2026Q1: 1,988,721 shares; 2026Q2: 876,970 shares; 2026Q3: 329,967 shares 329,967$20.6M1.02%-547,003Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 122,998 shares; 2026Q3: 207,000 shares 207,000$20.5M1.01%+84,002Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 118,513 shares; 2025Q3: 190,626 shares; 2025Q4: 157,641 shares; 2026Q1: 160,070 shares; 2026Q2: 76,489 shares; 2026Q3: 36,491 shares 36,491$19.8M0.98%-39,998Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 560,723 shares; 2025Q1: 593,403 shares; 2025Q2: 585,532 shares; 2025Q3: 739,876 shares; 2025Q4: 745,169 shares; 2026Q1: 818,328 shares; 2026Q2: 881,299 shares; 2026Q3: 621,691 shares 621,691$19.7M0.97%-259,608Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 73,315 shares; 2026Q2: 148,993 shares; 2026Q3: 144,054 shares 144,054$17.5M0.86%-4,939Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 132,927 shares; 2025Q1: 1,160,033 shares; 2025Q2: 1,032,362 shares; 2025Q3: 254,268 shares; 2025Q4: 287,690 shares; 2026Q1: 248,253 shares; 2026Q2: 493,536 shares; 2026Q3: 330,396 shares 330,396$16.6M0.82%-163,140Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,304,901 shares; 2025Q1: 2,304,901 shares; 2025Q2: 2,304,901 shares; 2025Q3: 2,293,788 shares; 2025Q4: 2,293,788 shares; 2026Q1: 2,293,788 shares; 2026Q2: 2,293,788 shares; 2026Q3: 2,293,788 shares 2,293,788$16.3M0.8%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,037,776 shares; 2025Q2: 1,216,016 shares; 2025Q3: 1,222,263 shares; 2025Q4: 1,096,705 shares; 2026Q1: 923,086 shares; 2026Q2: 945,690 shares; 2026Q3: 626,178 shares 626,178$16.2M0.8%-319,512Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 402,773 shares; 2025Q1: 342,218 shares; 2025Q2: 716,873 shares; 2025Q3: 520,240 shares; 2025Q4: 437,819 shares; 2026Q1: 386,498 shares; 2026Q2: 380,923 shares; 2026Q3: 396,598 shares 396,598$16.1M0.79%+15,675Timeline
IDXXIDEXX LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 29,145 shares 29,145$15.2M0.75%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,752 shares; 2025Q1: 7,485 shares; 2025Q2: 7,312 shares; 2025Q3: 13,553 shares; 2025Q4: 111,010 shares; 2026Q1: 78,320 shares; 2026Q2: 146,239 shares; 2026Q3: 231,628 shares 231,628$15.2M0.75%+85,389Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 865,135 shares; 2026Q3: 1,144,827 shares 1,144,827$14.4M0.71%+279,692Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 229,521 shares; 2026Q2: not reported; 2026Q3: 63,002 shares 63,002$14.2M0.7%newTimeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 565,199 shares; 2026Q3: 383,588 shares 383,588$13.6M0.67%-181,611Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 118,419 shares; 2025Q4: 438,630 shares; 2026Q1: 509,546 shares; 2026Q2: 471,763 shares; 2026Q3: 217,963 shares 217,963$13.2M0.65%-253,800Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 344,166 shares; 2026Q2: 255,903 shares; 2026Q3: 339,018 shares 339,018$12.9M0.64%+83,115Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 524,098 shares; 2026Q3: 523,673 shares 523,673$12.4M0.61%-425Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,795,880 shares; 2025Q1: 1,877,085 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 677,041 shares 677,041$9.93M0.49%newTimeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 110,108 shares 110,108$8.66M0.43%newTimeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 149,197 shares 149,197$3.17M0.16%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 545,771 shares; 2025Q2: 1,558,356 shares; 2025Q3: 136,862 shares; 2025Q4: 176,513 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 119,148 shares 119,148$2.88M0.14%newTimeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 211,802 shares 211,802$2.31M0.11%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,471,299 shares; 2025Q1: 5,481,666 shares; 2025Q2: 2,457,352 shares; 2025Q3: 2,427,724 shares; 2025Q4: 304,770 shares; 2026Q1: 364,763 shares; 2026Q2: 364,763 shares; 2026Q3: 356,224 shares 356,224$1.84M0.09%-8,539Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 47,506 shares; 2026Q2: 47,506 shares; 2026Q3: 46,217 shares 46,217$1.81M0.09%-1,289Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 23,100 shares; 2026Q1: 27,591 shares; 2026Q2: 27,591 shares; 2026Q3: 19,450 shares 19,450$1.66M0.08%-8,141Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 166,667 shares; 2026Q3: 162,380 shares 162,380$1.6M0.08%-4,287Timeline
PAHCPHIBRO ANIMAL HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 43,216 shares 43,216$1.54M0.08%newTimeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 107,391 shares; 2025Q3: 107,391 shares; 2025Q4: 107,391 shares; 2026Q1: 107,391 shares; 2026Q2: 107,391 shares; 2026Q3: 107,391 shares 107,391$1.51M0.07%0Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 222,654 shares; 2025Q4: 222,654 shares; 2026Q1: 222,654 shares; 2026Q2: 222,654 shares; 2026Q3: 222,654 shares 222,654$1.12M0.06%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 157,640 shares; 2025Q2: 15,717 shares; 2025Q3: 172,833 shares; 2025Q4: 125,722 shares; 2026Q1: 63,680 shares; 2026Q2: 6,440 shares; 2026Q3: 3,703 shares 3,703$1.08M0.05%-2,737Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 337,400 shares; 2026Q3: 80,817 shares 80,817$870K0.04%-256,583Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 141,700 shares; 2026Q2: 321,692 shares; 2026Q3: 312,553 shares 312,553$852K0.04%-9,139Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 209,500 shares 209,500$773K0.04%newTimeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 204,015 shares; 2026Q2: 32,267 shares; 2026Q3: 31,407 shares 31,407$687K0.03%-860Timeline
WVEWAVE LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 184,825 shares 184,825$684K0.03%newTimeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,436 shares; 2026Q3: 31,605 shares 31,605$615K0.03%-831Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 137,721 shares; 2025Q3: 137,721 shares; 2025Q4: 137,721 shares; 2026Q1: 137,721 shares; 2026Q2: 137,721 shares; 2026Q3: 137,721 shares 137,721$507K0.03%0Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 371,700 shares 371,700$439K0.02%newTimeline
LSTALISATA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 156,460 shares 156,460$225K0.01%newTimeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,884 shares; 2025Q4: 31,884 shares; 2026Q1: 31,884 shares; 2026Q2: 31,884 shares; 2026Q3: 31,884 shares 31,884$146K0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
IWMISHARES TR SHSput500,000$139Mnew
QQQINVESCO QQQ TR COMput75,000$55.5Mnew
BMYBRISTOL-MYERS SQUIBB CO COMcall700,000$43.7Mnew
IRONDISC MEDICINE INC Stockput200,000$13.1Mnew
EWTXEDGEWISE THERAPEUTICS INC COMput300,000$12.2Mnew
NKTRNEKTAR THERAPEUTICS COMMON STOCKput150,000$9.08Mnew
ANNXANNEXON INC COMcall555,300$2.35Mnew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SUPNSUPERNUS PHARMACEUTICALS1,036,328$48.2Mshares
GILDGILEAD SCIENCES INC343,100$43.3Mshares
COGTCOGENT BIOSCIENCES INC1,035,148$40.1Mshares
ALCALCON AG255,824$17.2Mshares
INSMINSMED INC158,398$16.9Mshares
RAREULTRAGENYX PHARMACEUTICAL IN500,000$16.7Mcall
ISRGINTUITIVE SURGICAL INC40,000$15.9Mcall
GMEDGLOBUS MED INC200,000$15.8Mcall
EXELEXELIXIS INC254,200$13.8Mput
TENXTENAX THERAPEUTICS INC500,039$7.28Mshares
SIONSIONNA THERAPEUTICS INC144,432$6.35Mshares
WVEWAVE LIFE SCIENCES LTD189,253$1.1Mshares
HTFLHEARTFLOW INC5,079$149Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-128032 base2026-11-16